For example, studies in prostate cancer [65-70], renal cell carcinoma [71], liver cancer [72], and breast cancer [73-75] have shown that AR activation can suppress cell proliferation, migration, and metastasis or induce apoptosis and differentiation programs counteracting malignant phenotypes. This evidence concerns the gene AR and renal cell carcinoma.